CAPN10
protein-codingcalpain 10, the group of Calpains
Gene summary
Calpains represent a ubiquitous, well-conserved family of calcium-dependent cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large catalytic subunit has four domains: domain I, the N-terminal regulatory domain that is processed upon calpain activation; domain II, the protease domain; domain III, a linker domain of unknown function; and domain IV, the calmodulin-like calcium-binding domain. This gene encodes a large subunit. It is an atypical calpain in that it lacks the calmodulin-like calcium-binding domain and instead has a divergent C-terminal domain. It is similar in organization to calpains 5 and 6. This gene is associated with type 2 or non-insulin-dependent diabetes mellitus (NIDDM), and is located within the NIDDM1 region. Multiple alternative transcript variants have been described for this gene. [provided by RefSeq, Sep 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~31.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0700092
Submitter: G2P
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CAPN10 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_023083.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 21 | 2 | 29 | ||
| missense | 127 | 14 | 6 | 147 | ||
| nonsense | 1 | 1 | 2 | |||
| start loss | 0 | |||||
| frameshift | 2 | 1 | 3 | |||
| splice donor/acceptor (+/-2bp) | 1 | 7 | 8 | |||
| Total | 3 | 1 | 142 | 35 | 8 | 189 |
Highest pathogenic variant AF is 0.000008894922
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_075571.2 | 12 | MANE Select | |
| Ensembl | ENSP00000375844.2 | 12 | MANE Select | |
| RefSeq | NP_075573.3 | 10 | Standard | |
| Ensembl | ENSP00000270361.11 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Integrin-mediated Cell Adhesion
- Extracellular matrix organization
- Degradation of the extracellular matrix
Biological Process
- proteolysis
- cellular component disassembly involved in execution phase of apoptosis
- actin cytoskeleton reorganization
- positive regulation of insulin secretion
- positive regulation of intracellular transport
Molecular Function
- SNARE binding
- calcium-dependent cysteine-type endopeptidase activity
- cytoskeletal protein binding
Cellular Component
- cytoplasm
- mitochondrion
- cytosol
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000391984
- Coding exons
- 12
- Length
- 30990
- Individuals with no LoFs
- 125671
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 76
- Defined
- 125747
- p
- 0.000302
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.17 | 357 | 425 | 0.841 | 0.0000282 | 4261 |
| Missense (PolyPhen) | 123 | 152.26 | 0.80784 | 1682 | ||
| Synonymous | -0.697 | 207 | 195 | 1.06 | 0.0000137 | 1426 |
| Loss of Function | 1.56 | 24 | 33.8 | 0.710 | 0.00000163 | 334 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.00079 | 0.00079 | rare |
| European (Non-Finnish) | 0.00029 | 0.00027 | rare |
| South Asian | 0.00017 | 0.00016 | rare |
| Other | 0.00066 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. May play a role in insulin-stimulated glucose uptake. {ECO:0000269|PubMed:17572128}.;
Recessive Scores
- pRec
- 0.211
Intolerance Scores
- LoFtool
- 0.111
- RVIS EVS
- -0.33
- RVIS percentile EVS
- 30.92
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.160
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |